Tokyo Tape
Sign in
← CellSeed

Half-year report · Q2

7776.TEDINET S100WJ5L
Period2025-01-01 → 2025-06-30
Filed2025-08-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 45
MetricValuePeriodScopeSource row
Revenue¥37m2025-01-01 → 2025-06-30StandaloneNet sales
Revenue¥193m2024-01-01 → 2024-12-31StandaloneNet sales (5-year summary)
Revenue¥76m2024-01-01 → 2024-06-30StandaloneNet sales
Operating income−¥623m2025-01-01 → 2025-06-30StandaloneOperating income
Operating income−¥464m2024-01-01 → 2024-06-30StandaloneOperating income
Ordinary income−¥624m2025-01-01 → 2025-06-30StandaloneOrdinary income
Ordinary income−¥848m2024-01-01 → 2024-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥463m2024-01-01 → 2024-06-30StandaloneOrdinary income
Profit before tax−¥651m2025-01-01 → 2025-06-30StandaloneIncome before income taxes
Profit before tax−¥473m2024-01-01 → 2024-06-30StandaloneIncome before income taxes
Net income−¥651m2025-01-01 → 2025-06-30StandaloneProfit loss
Net income−¥860m2024-01-01 → 2024-12-31StandaloneNet income loss (5-year summary)
Net income−¥474m2024-01-01 → 2024-06-30StandaloneProfit loss
Total assets¥1.9bnat 2025-06-30StandaloneAssets
Total assets¥2.4bnat 2024-12-31StandaloneAssets
Total assets¥2.4bnat 2024-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥400mat 2025-06-30StandaloneLiabilities
Total liabilities¥270mat 2024-12-31StandaloneLiabilities
Net assets / equity¥1.5bnat 2025-06-30StandaloneNet assets
Net assets / equity¥2.2bnat 2024-12-31StandaloneNet assets
Net assets / equity¥2.1bnat 2024-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.7bnat 2025-06-30StandaloneCash and deposits
Cash and deposits¥2.1bnat 2024-12-31StandaloneCash and deposits
Cash & equivalents¥1.7bnat 2025-06-30StandaloneCash and cash equivalents
Cash & equivalents¥2.1bnat 2024-12-31StandaloneCash and cash equivalents
Cash & equivalents¥2.2bnat 2024-06-30StandaloneCash and cash equivalents
Cash & equivalents¥2.2bnat 2023-12-31vStandaloneCash and cash equivalents
Operating cash flow−¥473m2025-01-01 → 2025-06-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥866m2024-01-01 → 2024-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥405m2024-01-01 → 2024-06-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥717,0002025-01-01 → 2025-06-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥18m2024-01-01 → 2024-12-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥6m2024-01-01 → 2024-06-30StandaloneNet cash provided by used in investment activities
Financing cash flow−¥4m2025-01-01 → 2025-06-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥855m2024-01-01 → 2024-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥422m2024-01-01 → 2024-06-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-18.782025-01-01 → 2025-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-25.722024-01-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-14.742024-01-01 → 2024-06-30StandaloneBasic earnings loss per share (5-year summary)
Equity ratio78.5%at 2025-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio88.5%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio86.4%at 2024-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued34,666,419at 2025-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued34,666,419at 2024-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued33,447,119at 2024-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30−¥115m
jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue2025-01-01 → 2025-06-30¥2m
jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue external2025-01-01 → 2025-06-30¥2m
jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segmentsegment profit2025-01-01 → 2025-06-30−¥449m
jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue2025-01-01 → 2025-06-30¥35m
jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue external2025-01-01 → 2025-06-30¥35m
jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segmentsegment profit2025-01-01 → 2025-06-30−¥59m
—segment totalrevenue2025-01-01 → 2025-06-30¥37m
—segment totalrevenue external2025-01-01 → 2025-06-30¥37m
—segment totalsegment profit2025-01-01 → 2025-06-30−¥508m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30−¥113m
jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue2024-01-01 → 2024-06-30¥1m
jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue external2024-01-01 → 2024-06-30¥1m
jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segmentsegment profit2024-01-01 → 2024-06-30−¥332m
jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue2024-01-01 → 2024-06-30¥75m
jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue external2024-01-01 → 2024-06-30¥75m
jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segmentsegment profit2024-01-01 → 2024-06-30−¥19m
—segment totalrevenue2024-01-01 → 2024-06-30¥76m
—segment totalrevenue external2024-01-01 → 2024-06-30¥76m
—segment totalsegment profit2024-01-01 → 2024-06-30−¥351m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 429
ItemContextValueUnit
Valuation and translation adjustmentsCurrentQuarterInstant_NonConsolidatedMember1554000JPY
Subscription rights to sharesPrior1YearInstant_NonConsolidatedMember10384000JPY
Subscription rights to sharesCurrentQuarterInstant_NonConsolidatedMember10384000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember2163204000JPY
Net assetsCurrentQuarterInstant_NonConsolidatedMember1512848000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember2433084000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember1912989000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember76303000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember36998000JPY
Cost of salesPrior1YTDDuration_NonConsolidatedMember34580000JPY
Cost of salesCurrentYTDDuration_NonConsolidatedMember22653000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember41723000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember14344000JPY
Research and development expenses sgaPrior1YTDDuration_NonConsolidatedMember322338000JPY
Research and development expenses sgaCurrentYTDDuration_NonConsolidatedMember451208000JPY
Other sgaPrior1YTDDuration_NonConsolidatedMember183555000JPY
Other sgaCurrentYTDDuration_NonConsolidatedMember186406000JPY
Selling general and administrative expensesPrior1YTDDuration_NonConsolidatedMember505893000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember637615000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember-464170000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-623270000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember10000JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember1100000JPY
Foreign exchange gains noiPrior1YTDDuration_NonConsolidatedMember2936000JPY
Foreign exchange gains noiCurrentYTDDuration_NonConsolidatedMember－JPY
Other noiPrior1YTDDuration_NonConsolidatedMember439000JPY
Other noiCurrentYTDDuration_NonConsolidatedMember18000JPY
Non operating incomePrior1YTDDuration_NonConsolidatedMember3386000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember1119000JPY
Interest expenses noePrior1YTDDuration_NonConsolidatedMember1036000JPY
Interest expenses noeCurrentYTDDuration_NonConsolidatedMember978000JPY
Foreign exchange losses noePrior1YTDDuration_NonConsolidatedMember－JPY
Foreign exchange losses noeCurrentYTDDuration_NonConsolidatedMember839000JPY
Stock issuance cost prior noePrior1YTDDuration_NonConsolidatedMember1536000JPY
Stock issuance cost prior noeCurrentYTDDuration_NonConsolidatedMember－JPY
Non operating expensesPrior1YTDDuration_NonConsolidatedMember2572000JPY
Non operating expensesCurrentYTDDuration_NonConsolidatedMember1817000JPY
Ordinary incomePrior1YTDDuration_NonConsolidatedMember-463355000JPY
Ordinary incomeCurrentYTDDuration_NonConsolidatedMember-623969000JPY
Gain on reversal of subscription rights to shares eiPrior1YTDDuration_NonConsolidatedMember2055000JPY
Gain on reversal of subscription rights to shares eiCurrentYTDDuration_NonConsolidatedMember－JPY
Extraordinary incomePrior1YTDDuration_NonConsolidatedMember2055000JPY
Extraordinary incomeCurrentYTDDuration_NonConsolidatedMember－JPY
Impairment loss elPrior1YTDDuration_NonConsolidatedMember12014000JPY
Impairment loss elCurrentYTDDuration_NonConsolidatedMember26717000JPY
Extraordinary lossPrior1YTDDuration_NonConsolidatedMember12014000JPY
Extraordinary lossCurrentYTDDuration_NonConsolidatedMember26717000JPY
Income before income taxesPrior1YTDDuration_NonConsolidatedMember-473314000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember-650687000JPY
Income taxes currentPrior1YTDDuration_NonConsolidatedMember1145000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2024-12-31pass
balance sheet identitynon_consolidated 2025-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2024-12-31pass
statement vs summary · net assetsnon_consolidated 2025-06-30pass
statement vs summary · operating cash flownon_consolidated 2024-01-01/2024-06-30pass
statement vs summary · operating cash flownon_consolidated 2025-01-01/2025-06-30pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-06-30pass
statement vs summary · revenuenon_consolidated 2025-01-01/2025-06-30pass
statement vs summary · total assetsnon_consolidated 2024-12-31pass
statement vs summary · total assetsnon_consolidated 2025-06-30pass